In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Oncology Institute Inc (NASDAQ: TOI) closed the day trading at $3.13 down -3.40% from the previous closing price of $3.24. In other words, the price has decreased by -$3.40 from its previous closing price. On the day, 2.1 million shares were traded. TOI stock price reached its highest trading level at $3.27 during the session, while it also had its lowest trading level at $3.07.
Ratios:
For a better understanding of TOI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.39 and its Current Ratio is at 1.68.
Upgrades & Downgrades
In the most recent recommendation for this company, Noble Capital Markets on July 23, 2025, initiated with a Outperform rating and assigned the stock a target price of $8.
On July 16, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $6.
On May 15, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $7.BTIG Research initiated its Buy rating on May 15, 2025, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 ’25 when Pacala Mark L sold 50,000 shares for $4.00 per share. The transaction valued at 200,000 led to the insider holds 174,971 shares of the business.
MARK PACALA bought 50,000 shares of TOI for $200,000 on Nov 18 ’25. On Sep 04 ’25, another insider, M33 Growth I L.P., who serves as the Director of the company, sold 6,018,168 shares for $3.09 each. As a result, the insider received 18,596,139 and left with 7,932,389 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOI now has a Market Capitalization of 307933632 and an Enterprise Value of 383899584. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.67. Its current Enterprise Value per Revenue stands at 0.833 whereas that against EBITDA is -11.263.
Stock Price History:
The Beta on a monthly basis for TOI is 0.31, which has changed by 19.592106 over the last 52 weeks, in comparison to a change of 0.1028198 over the same period for the S&P500. Over the past 52 weeks, TOI has reached a high of $4.88, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is -17.28%, while the 200-Day Moving Average is calculated to be 12.73%.
Shares Statistics:
Over the past 3-months, TOI traded about 2.15M shares per day on average, while over the past 10 days, TOI traded about 3815840 shares per day. A total of 97.57M shares are outstanding, with a floating share count of 66.12M. Insiders hold about 32.79% of the company’s shares, while institutions hold 31.07% stake in the company. Shares short for TOI as of 1761868800 were 4788151 with a Short Ratio of 2.22, compared to 1759190400 on 5098841. Therefore, it implies a Short% of Shares Outstanding of 4788151 and a Short% of Float of 6.25.
